Cite

HARVARD Citation

    Bolland, M. et al. (2019). Effects of Intravenous Zoledronate on Bone Turnover and Bone Density Persist for at Least 11 Years in HIV‐Infected Men. Journal of bone and mineral research. pp. 1248-1253. [Online]. 
  
Back to record